![]() |
|
Tablet
Film Coatings, Hydro Alcoholic Film Coatings, Tablet Coating Films |
Normal
Film Coating
Enteric Coating Moisture Shield Coating Sustained Release Coating Specialty Products |
| Sample
Requirement Form |
| Product | Description | Reconstitution level | Average weight gain * | Application ** examples |
| Instacoat Aqua | HPMC based Aqueous System | 11 % | 2.5 % | Amoxycilin, Azithromycin Atenolol, Amlodipine, Acelofenac, Amtriptyline, Ampicilin HCI, Ciprofloxacin, Cefadroxil, HCI, Celecoxib, Cimitidine, Calcium Tablets, Certizine, HCI, Clarithromycin, Chloroquine Phosphate Erithromycin estoate, Erthromycin striate, Enalpril, Maleate, Elctronxib, Ferrous, fumarate, Famotidine Flupenthixol Fluoxetine Felodipine, Gatifloxacin, Gliclazide, Ibuprofen, Indapamide, Ketorolac, Ketoprofen, Levofixation, Levocetrinzie, Losartan, Potassium, Levamisole, Metormin, Methylopa, Metra + Tetraozole, Metronidozole, Methyl, Comblamine, Mefenamic acid, Metropralal Nifedipne, Norfloxacin, Nifedopine, Norfloxacin Norflax+Tindazole, Oflaxacin, Oflaxacin+Omidazole, Olazzapine, Orridazole, Oflexacin + Omidazole Paracetamol, Pravastain, Prmethazine, Quinine, sulphate, Primaquine, Ramipril,Tindazole, Tiri+Doxicycline Tiri + Tetracyline, Valdecoxib, Verapamil, All herbal & Neutraceuticls |
| Instacoat Sol | HPMC based Organic Solvent System | 5% | 2.5% | |
| Instacoat Universal | HPMC based Aqueous / Organic / Hydro-Alcoholic System | Aqueous 11 % Organic Solvent - 5% Hydro Alcoholic - 9% |
2.5% | |
| Instacoat Aqua -II | Grafted PVA based Aqueous System | 20% | 2.5% | |
| Instacoat Aqua -III | HPMC based Aqueous System | 15% | 2.5% | |
| Instacoat - P4 | SA based Aqueous System | 20% | 2.5% | |
| Instacoat Herbo | Customized Polymer based Aqueous/ Organic System | Aqueous 11% to 20 % Organic - 5% | 5% | |
| Instacoat Natcol | Aqueous / Organic System with Natural Colourants | Aqueous 11% to 20 % Organic - 5% | 5% |
| *
|
Depends on coating facilities, at customer's premises and product to be coated |
| ** |
Confirm with us the suitability of the INSTACOAT Coating System compatible with the active pharmaceutical ingredient |